Patent · US Active

Recombinant adipose-derived stem cell and recombinant method thereof

US11542474B2 · kind B2 · utility

0Cited by
0References
6Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 30, 2019
Grant dateJan 3, 2023
Priority date
Expiry dateMay 23, 2041

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2710/10343
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

The present invention provides a recombinant adipose-derived stem cell and a recombinant method thereof, and belongs to the technical field of genetic engineering, where an adenovirus carrying an hFIX gene is transfected into an adipose-derived stem cell to obtain the recombinant adipose-derived stem cell. In the present invention, an adenovirus carrying an hFIX gene is transfected into an adipose-derived stem cell, and the recombinant adipose-derived stem cell obtained after the transfection can express an hFIX protein.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.